Background Noncompaction of left ventricular myocardium is a rare congenital cardiomyopathy resulting from an incomplete myocardial morphogenesis that leads to the persistence of the embryonic myocardium. This condition is characterized by a thin compacted epicardial and an extremely thickened endocardial layer with prominent trabeculations and deep intertrabecular recesses. It is not clear, in noncompaction of myocardium, whether intertrabecular recesses could be responsible for thrombi formation and thromboembolic complications. Methods The prevalence of stroke and echocardiographic finding of thrombus was evaluated in a continuous series of 229 patients (men and women) affected by noncompaction of the left ventricular myocardium, who were included in the SIEC registry. We excluded patients affected by atrial fibrillation. Results The mean age of the patients was 49.5 years. Fifty percent of the patients were affected by a ventricular systolic dysfunction. The mean period of follow-up was 7.3 years. Only four patients had a history of ischemic stroke. A large thrombus into the left ventricular chamber was observed in a 1-year-old child affected by Behcet's disease (high risk of thrombi formation). Conclusion Noncompaction of the left ventricular myocardium, by itself, does not seem to be a risk factor for stroke or embolic results, so there is no indication for oral anticoagulant therapy.

FAZIO G, CORRADO G, ZACHARA E, RAPEZZI C, SULAFA AK, SUTERA L, et al. (2008). Anticoagulant drugs in noncompaction: a mandatory therapy?. JOURNAL OF CARDIOVASCULAR MEDICINE, 9, 1095-1097 [10.2459/JCM.0b013e328308da04].

Anticoagulant drugs in noncompaction: a mandatory therapy?

DI GESARO, Gabriele;D'ANGELO, Luciana;NOVO, Giuseppina;MONGIOVI', Maria Stella;FERRARA, Filippo;PIPITONE, Sergio;NOVO, Salvatore
2008

Abstract

Background Noncompaction of left ventricular myocardium is a rare congenital cardiomyopathy resulting from an incomplete myocardial morphogenesis that leads to the persistence of the embryonic myocardium. This condition is characterized by a thin compacted epicardial and an extremely thickened endocardial layer with prominent trabeculations and deep intertrabecular recesses. It is not clear, in noncompaction of myocardium, whether intertrabecular recesses could be responsible for thrombi formation and thromboembolic complications. Methods The prevalence of stroke and echocardiographic finding of thrombus was evaluated in a continuous series of 229 patients (men and women) affected by noncompaction of the left ventricular myocardium, who were included in the SIEC registry. We excluded patients affected by atrial fibrillation. Results The mean age of the patients was 49.5 years. Fifty percent of the patients were affected by a ventricular systolic dysfunction. The mean period of follow-up was 7.3 years. Only four patients had a history of ischemic stroke. A large thrombus into the left ventricular chamber was observed in a 1-year-old child affected by Behcet's disease (high risk of thrombi formation). Conclusion Noncompaction of the left ventricular myocardium, by itself, does not seem to be a risk factor for stroke or embolic results, so there is no indication for oral anticoagulant therapy.
FAZIO G, CORRADO G, ZACHARA E, RAPEZZI C, SULAFA AK, SUTERA L, et al. (2008). Anticoagulant drugs in noncompaction: a mandatory therapy?. JOURNAL OF CARDIOVASCULAR MEDICINE, 9, 1095-1097 [10.2459/JCM.0b013e328308da04].
File in questo prodotto:
File Dimensione Formato  
fazio2008.pdf

non disponibili

Dimensione 74.88 kB
Formato Adobe PDF
74.88 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/355399
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 42
  • ???jsp.display-item.citation.isi??? 32
social impact